MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fneur.2026.1765246

Медицинская библиотека · Frontiers in neurology · 2026

Latent-profile analysis of sleep disturbances, cognitive performance and neuropsychiatric symptoms reveals subtypes of Parkinson's disease.

El Haffaf Lyna Mariam, Domellöf Magdalena Eriksson, Ronat Lucas, Monchi Oury, Walton Lois, Bäckström David, Boraxbekk Carl-Johan, Forsgren Lars, Nyberg Lars, Neely Anna Stigsdotter, Johansson Jarkko

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Given the clinical heterogeneity of Parkinson's disease (PD), identification of early -stage subgroups with shared non-motor symptom (NMS) profiles may clarify its pathophysiology. This study used latent-profile analyses (LPA) to define subgroups based on sleep disturbances, cognitive performance and neuropsychiatric symptoms, and examined dopaminergic function and brain volume differences between them.

METHODS

We analyzed data from 51 cognitively normal non-PD older adults and 105 early-stage PD participants from the iPARK trial, including 19 who underwent [11C]-raclopride PET/MR. Participants completed the Hospital Anxiety and Depression Scale, the short version of the Karolinska Sleep Questionnaire and a battery of neuropsychological tests. LPA were used in PD to identify subgroups based on NMS profiles, which were then characterized and examined in relation to dopaminergic integrity and brain morphology.

RESULTS

LPA identified a two-cluster solution as the best fit. Group 1 (N = 49) showed poorer working memory, executive function and processing speed along with greater daytime sleepiness, depression and anxiety. Group 2 (N = 56) exhibited less affected cognitive function and minimal NMS. Groups were similar in demographics, disease duration, motor symptom severity and medication, but differed on UPDRS-1 NMS. Group 1 demonstrated significantly reduced [11C]-raclopride binding potential compared to Group 2 in the left putamen at both ROI- and voxel-wise analysis.

CONCLUSION

These findings indicate clinically distinct subgroups in early-stage PD. Greater NMS burden is linked to impaired dopaminergic integrity, suggesting a potential neurobiological signature. Early identification of such subgroups may improve understanding of disease heterogeneity and support personalized management and interventions.

CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/study/NCT03680170?id=NCT03680170&rank=1, identifier (NCT03680170).

Для цитирования: El Haffaf Lyna Mariam, Domellöf Magdalena Eriksson, Ronat Lucas, Monchi Oury, Walton Lois, Bäckström David, Boraxbekk Carl-Johan, Forsgren Lars, Nyberg Lars, Neely Anna Stigsdotter, Johansson Jarkko. Latent-profile analysis of sleep disturbances, cognitive performance and neuropsychiatric symptoms reveals subtypes of Parkinson's disease.. Frontiers in neurology. 2026. DOI: 10.3389/fneur.2026.1765246.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.